AstraZeneca Says No to Pfizer's $119B Takeover Bid

The board of AstraZeneca rejected the improved $119 billion takeover offer from U.S. drugmaker Pfizer, a decision that has led to a slide in the U.K. company's share price. In a statement Monday, AstraZeneca's board said it "reiterates its confidence in AstraZeneca's ability to deliver on its prospects as an independent, science led business." Read the full story

More News:

All news »

What are your comments?

You cannot post comments until you have logged in. Login Here.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments